Skip to content

Net margin at other companies

Amgen logo
AmgenAMGN
21%+3.6pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
29.6%-2.3pp
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-606.2%-212pp
Immunome logo
ImmunomeIMNM
-5,593.8%-11,284pp
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
-123.9%-28.4pp
Incyte logo
IncyteINCY
26.7%+26.2pp

Other financials

Income statement

See full
Revenue$10.9M+3.8%
Gross profit$21.8M+2.9%
Operating income-$39.1M+12.3%
Net income-$44.9M+11.7%
EPS (diluted)-$1.82+49.7%

Balance sheet

See full
Cash & equivalents$5.7M-20.0%
Total debt$83.2M-17.1%
Total equity$576.2M+4,094%
Total assets$763.3M+198%

Cash flow

See full
Operating cash flow-$44.3M+9.7%
CapEx$18.0K+800%
Free cash flow-$44.3M+9.7%

Valuation

See full
Market cap$2.25B+1,531%
Enterprise value$2.33B+874%
P/S40.5×+38.9×

Profitability

See full
Gross margin100%+31.2pp
Operating margin-242%
FCF margin-366.6%+1,421pp

Returns & leverage

See full
Return on equity-53.6%-22.6pp
Debt / equity0.1×-7.2×
Current ratio10.2×+7.0×

Where this comes from

Calculated from Nektar Therapeutics’s reported figures.

Based on trailing twelve months.

The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nektar Therapeutics's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nektar Therapeutics's net margin?
Nektar Therapeutics (NKTR) reported net margin of -284.2% in Q1 2026.
How has Nektar Therapeutics's net margin changed year-over-year?
Nektar Therapeutics's net margin decreased by 76.7% year-over-year, from -160.8% to -284.2%.
What is the long-term trend for Nektar Therapeutics's net margin?
Over 5 years (2020 to 2025), Nektar Therapeutics's net margin has grown at a 0.4% compound annual growth rate (CAGR), from -290.6% to -297.1%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.